The majority of states in the U.S. now allow for some form of medical marijuana.

Each state has different regulations for medical marijuana and its availability to patients and adults 18+. In particular, qualifying health conditions for medical marijuana vary greatly from state to state, which can make it confusing for patients who would qualify in one state but not another.

Qualifying conditions for medical marijuana are state-specific lists of medical conditions that allow patients to legally obtain their medical card. Patients with one of these conditions can work with a doctor to get the necessary approval to buy and use medical cannabis.

Medical patients are often given greater priority and more affordable pricing than adult-use customers, so it’s still worth looking into getting your medical marijuana card, even if your state allows adult-use cannabis. Here are the qualifying conditions for a medical marijuana card in each legal state.

What Conditions Qualify for Medical Marijuana?

Before considering what medical conditions qualify for medical marijuana, what you need to know is that each state regulates the medical use of cannabis differently.

Based on where you live, take a look at our comprehensive list below to understand what conditions qualify for medical marijuana. Find your state to get started.

Alabama

Alabama legalized medical cannabis on May 17, 2021, and will soon allow the sale and use of medical cannabis products. Flower, vape products, and edibles are prohibited. Still, medical cannabis can be used in various forms such as oral tablets, capsules, tinctures, gels, oils, creams or other topicals, patches, nebulizers, and inhalers.

Qualifying health conditions for Alabama’s medical marijuana program include:

Cancer-related weight loss, chronic pain, nausea or vomiting, or Cachexia/Wasting Syndrome
Post-Traumatic Stress Disorder (PTSD)
Depression
Crohn’s Disease
Epilepsy
Autism Spectrum Disorder
Chronic or intractable pain that has not been effectively treated with opioids or for which opioid therapy is inadvisable
Sickle Cell Anemia
HIV/AIDS-related nausea or weight loss
Panic disorder
Parkinson’s disease
Persistent nausea that has not been alleviated by more common treatments and that is not caused by pregnancy or marijuana use
Spasticity related to a spinal cord injury, MS, ALS, or some other motor neuron disease
A terminal illness
Tourette’s Syndrome

Alaska

Alaska has allowed medical cannabis since 1998 and adult-use cannabis since 2014.

Qualifying health conditions for Alaska’s medical marijuana program include:

Cachexia or Wasting Syndrome
Cancer
Chronic pain
Glaucoma
HIV or AIDS
Multiple sclerosis
Nausea
Persistent Muscle Spasms
Seizures

Arizona

Arizona legalized medical cannabis in 2010 and adult-use cannabis in 2020.

Qualifying health conditions for Arizona’s medical marijuana program include:

Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Crohn’s disease
Glaucoma
Hepatitis C
HIV or AIDS
Nausea
Persistent muscle spasms
PTSD
Seizures

Arkansas

In 2016, voters in Arkansas approved new medical marijuana laws. In August 2017, the state opened its first dispensary application round.

Qualifying health conditions for Arkansas’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Alzheimer’s disease
Cachexia or Wasting Syndrome
Cancer
Chronic or debilitating disease
Crohn’s disease
Fibromyalgia
Glaucoma
Hepatitis C
HIV/AIDS
Intractable pain
Multiple sclerosis
Peripheral neuropathy
PTSD
Seizures
Severe arthritis
Severe nausea
Severe and persistent muscle spasms
Tourette’s syndrome
Ulcerative colitis
Any medical condition or its treatment approved by the Department of Health

California

California has had one of the most extensive, most active medical marijuana programs as they were the first to do so in a vote in 1996 and have since legalized adult-use cannabis in late 2016.

Qualifying health conditions for California’s medical marijuana program include:

Anorexia
Arthritis
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
HIV/AIDS
Glaucoma
Migraine
Persistent Muscle Spasms
Severe Nausea
Seizures
Any debilitating illness where the medical use of marijuana has been “deemed appropriate and has been recommended by a physician.”

Colorado

Like California, Colorado has a longstanding medical marijuana program that launched in 2000. Colorado launched their adult-use cannabis program in 2012, and it has become a popular cannabis destination for visitors to The Centennial State

Qualifying health conditions for Colorado’s medical marijuana program include:

An Autism Spectrum Disorder
Any condition for which a physician would prescribe an opioid
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Chronic nervous system disorders
Glaucoma
HIV/AIDS
Nausea
Persistent Muscle Spasms
Post Traumatic Stress Syndrome
Seizures

Connecticut

Connecticut signed its medical marijuana program into law in 2012 and now allows for adult use, as of July 1, 2021.

Qualifying health conditions for Connecticut’s medical marijuana program include:’

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cachexia or Wasting Syndrome
Cancer
Cerebral Palsy
Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders
Chronic Pain of at least six months duration associated with a specified underlying chronic condition refractory to other treatment intervention
Chronic Pancreatitis
Complex regional pain syndrome
Crohn’s disease
Cystic Fibrosis
Ehlers-Danlos Syndrome Associated with Chronic Pain
Epilepsy
Glaucoma
HIV or AIDS
Hydrocephalus with Intractable Headache
Interstitial Cystitis
Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments
Intractable spasticity
Intractable Headache Syndromes
Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity
MALS Syndrome (Median Arcuate Ligament Syndrome)
Movement disorders associated with Huntington Disease
Multiple Sclerosis
Muscular Dystrophy
Neuropathic Facial Pain
Osteogenesis Imperfecta
Parkinson’s Disease
Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome
Post Herpetic Neuralgia
Post-surgical back pain with a condition called chronic radiculopathy
Post Laminectomy Syndrome
Post-Traumatic Stress Disorder (PTSD)
Severe psoriasis and psoriatic arthritis
Severe Rheumatoid Arthritis
Sickle cell disease
Spasticity or Neuropathic Pain Associated with Fibromyalgia
Terminal Illness Requiring End-Of-Life Care
Tourette Syndrome
Ulcerative colitis
Uncontrolled Intractable Seizure Disorder
Other medical conditions may be approved by the Department of Consumer Protection.
Vulvodynia and Vulvar Burning

Delaware

Delaware passed the Delaware Medical Marijuana Act in May 2011 and decriminalized cannabis in December 2015.

Qualifying health conditions for Delaware’s medical marijuana program include:

Autism with self-injurious or aggressive behavior
Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gherig’s Disease)
Cachexia or Wasting Syndrome
Cancer
Chronic Debilitating Migraines
Chronic pain
Decompensated Cirrhosis
Glaucoma
HIV/AIDS
Intractable epilepsy*
Multiple Sclerosis
Nausea
Post-traumatic Stress Disorder (PTSD)
Seizures
Severe and persistent muscle spasms
Terminal Illness

Florida

Florida’s Compassionate Medical Cannabis Act has been in effect since 2015.

Qualifying health conditions for Florida’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cancer
Crohn’s disease
Chronic nonmalignant pain*
Epilepsy
Glaucoma
HIV/AIDS
Multiple sclerosis
Muscle spasms
Parkinson’s disease
PTSD
Seizures
Terminal illness (patients diagnosed with no more than 12-months to live)
Other debilitating medical conditions comparable to those enumerated

Georgia

Georgia has had a medical cannabis program since it signed the “Haleigh’s Hope Act” on April 16th, 2015.

Qualifying health conditions for Georgia’s medical marijuana program include:

AIDS
Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Autism
Cancer
Crohn’s disease
Epidermolysis Bullosa
Hospice care patients
Intractable pain
Mitochondrial disease
Multiple sclerosis
Parkinson’s disease
Post-Traumatic Stress Disorder (PTSD)
Severe or end-stage Peripheral neuropathy
Seizure disorder
Sickle cell disease
Tourette’s syndrome

Hawaii

Hawaii became the first state to legalize medical cannabis through an act of state legislature rather than through the standard ballot initiative process in 2000. Their program has since undergone many revisions, and it officially decriminalized cannabis in 2020.

Qualifying health conditions for Hawaii’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Crohn’s disease
Epilepsy
Glaucoma
HIV or AIDS
Lupus
Multiple sclerosis
Nausea
Persistent muscle spasms
Post-traumatic stress disorder (PTSD)
Rheumatoid arthritis
Seizures

Illinois

Illinois started its robust medical marijuana program in 2013 and has since fully legalized adult-use cannabis in May of 2019.

Qualifying health conditions for Illinois’ medical marijuana program include:

Autism
Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Anorexia Nervosa
Arnold Chiari malformation
Cachexia/wasting syndrome
Cancer
Causalgia
Chronic Inflammatory Demyelinating Polyneuropathy
Complex regional pain syndrome type 2 (CRPS)
Crohn’s Disease
Dystonia
Ehlers-Danlos Syndrome
Fibromyalgia
Fibrous dysplasia
Glaucoma
Hepatitis C
HIV/AIDS
Hydrocephalus
Hydromyelia
Interstitial Cystitis
Irritable Bowel Syndrome (IBS)
Lupus
Migraines
Multiple Sclerosis
Muscular Dystrophy
Myasthenia Gravis
Myoclonus
Nail-patella syndrome
Neurofibromatosis
Neuropathy
Osteoarthritis
Parkinson’s disease
Polycystic Kidney Disease (PKD)
Post-traumatic stress disorder (PTSD)
Reflex Sympathetic Dystrophy (RSD)
Residual limb pain
Rheumatoid Arthritis
Seizures
Sjogren’s syndrome
Spinal cord disease
Spinocerebellar Ataxia (SCA)
Superior Canal Dehiscence Syndrome
Syringomyelia
Tarlov cysts
Tourette’s syndrome
Traumatic brain injury and post-concussion syndrome
Ulcerative Colitis

Indiana

Indiana’s medical CBD program was signed into law in 2018 and is limited to CBD products only.

Qualifying health conditions for Indiana’s Medical CBD program include:

Severe epilepsy resistant to other treatments
Dravet syndrome
Lennox-Gastaut syndrome

Iowa

Starting in December 2018, patients in Iowa with one of the following conditions and the proper recommendations can use certain CBD extracts.

Qualifying health conditions for Iowa’s medical CBD program include:

AIDS/HIV
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cancer
Cancer-related chronic pain, nausea, or cachexia
Corticobasal Degeneration
Crohn’s disease
Multiple sclerosis
Parkinson’s disease
Post-traumatic Stress Disorder
Intractable epilepsy
Seizures
Severe, intractable autism with self-injurious or aggressive behaviors
Terminal illness
Ulcerative Colitis
Untreatable pain

Kentucky

Kentucky has a narrow and relatively restrictive medical marijuana program that only includes CBD. However, there have been talks around potential official legalization that will hopefully arrive sooner than later.

Qualifying health conditions for Kentucky’s medical CBD program include:

Intractable epilepsy

Louisiana

In Louisiana, the Therapeutic Marijuana Act approved the vaporization of medical cannabis with an inhaler in 2019 but has since revised its program to allow for the smoking of cannabis starting on January 1st, 2022.

Qualifying health conditions for Louisiana’s medical marijuana program include:

Autism Spectrum disorders
Cachexia or Wasting Syndrome
Cancer
Crohn’s disease
Epilepsy
Glaucoma
HIV/AIDS
Intractable Pain
Muscular dystrophy
Multiple sclerosis
Parkinson’s disease
Post-traumatic Stress Disorder (PTSD)
Seizure disorders/spasticity
Severe muscle spasms

Maine

Medical cannabis has been legal in Maine since 1999, and voters in Maine approved the legalization of adult-use cannabis in 2016.

Qualifying health conditions for Maine’s medical marijuana program include:

Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cachexia or wasting syndrome
Cancer
Chronic pain
Crohn’s disease
Epilepsy
Glaucoma
Hepatitis C
HIV or AIDS
Huntington’s disease
Inflammatory bowel disease
Multiple Sclerosis
Nausea
Nail-patella syndrome
Parkinson’s disease
Post-traumatic stress disorder (PTSD)

Maryland

Maryland decriminalized and legalized medical cannabis in 2014.

Qualifying health conditions for Maryland’s medical marijuana program include:

Cachexia or Wasting Syndrome
Anorexia
Chronic Pain
Glaucoma
Nausea
Post-Traumatic Stress Disorder
Seizures
Severe or persistent muscle spasms
A chronic medical condition that is severe and for which other treatments have been ineffective

Massachusetts

Massachusetts launched its medical cannabis program in 2013 and since legalized adult-use cannabis in 2016.

Qualifying health conditions for Massachusetts’ medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS)
Anxiety
Cachexia or Wasting Syndrome
Cancer
Crohn’s disease
Glaucoma
HIV or AIDS
Hepatitis C
Multiple Sclerosis
Parkinson’s disease
Post-Traumatic Stress Disorder (PTSD)
Other conditions as determined in writing by a qualifying patient’s physician.

Michigan

Michigan has had a robust and active medical marijuana program since 2008 and legalized adult-use cannabis in 2018.

Qualifying health conditions for Michigan’s medical marijuana program include:

Autism
Alzheimer’s disease
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease)
Arthritis
Cachexia or wasting syndrome
Cancer
Cerebral Palsy
Chronic pain
Colitis
Crohn’s disease
Glaucoma
HIV or AIDS
Hepatitis C
Inflammatory Bowel Disease (IBD)
Nail-patella
Nausea
Obsessive-Compulsive Disorder (OCD)
Parkison’s Disease
Post-traumatic stress disorder (PTSD)
Rheumatoid Arthritis
Seizures
Severe and persistent muscle spasms
Spinal cord injury
Tourette’s Disease
Ulcerative Colitis

Minnesota

In Minnesota, medical cannabis has been legal since 2014. Patients can only purchase non-smokable forms of cannabis, but a recent revision to the program allows for the smoking of cannabis. The modification will take effect by March 1st, 2022, or once a procedure is in place to test dried raw cannabis from the state’s existing manufacturers.

Qualifying health conditions for Minnesota’s medical marijuana program include:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease)
Autism
Cancer
Chronic Motor or Vocal Tic Disorder
Chronic Pain
Crohn’s disease
Epilepsy
Glaucoma
HIV/AIDS
Inflammatory Bowel Disease (IBD)
Intractable pain
Multiple Sclerosis
Obstructive Sleep Apnea
Post-traumatic stress disorder (PTSD)
Seizures
Severe and persistent muscle spasms
Sickle Cell Disease
Terminal illness
Tourette’s Syndrome

Mississippi

Possessing a small amount of cannabis has been decriminalized since 1978, but after a rocky road for legislation, Mississippi now offers a comprehensive medical marijuana program as of February 2nd, 2022.

Qualifying health conditions for Mississippi’s medical marijuana program include:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Autism
Cachexia or Wasting Syndrome
Cancer
Crohn’s Disease
Chronic Pain
Dementia
Diabetic / Peripheral Neuropathy
Glaucoma
HIV/AIDS
Hepatitis
Huntington’s Disease
Multiple Sclerosis
Muscular Dystrophy
Pain refractory to appropriate opioid management
Parkinson’s Disease
Post-Traumatic Stress Disorder (PTSD)
Seizures
Severe and persistent muscle spasms
Severe or intractable nausea
Spastic Quadriplegia
Spinal cord disease or severe injury
Sickle-Cell Anemia
Ulcerative Colitis

Missouri

Missouri decriminalized cannabis in 2014 and legalized medical cannabis in 2018. The medical program launched in October 2020.

Qualifying health conditions for Missouri’s medical marijuana program include:

A chronic medical condition that is normally treated with prescription medications that could lead to physical or psychological dependence
Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Autism
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Crohn’s disease
Debilitating psychiatric disorders
Epilepsy
Glaucoma
Hepatitis C
HIV/AIDS
Huntington’s Disease
Inflammatory Bowel Disease (IBD)
Intractable migraines unresponsive to other treatment
Multiple Sclerosis
Neuropathies
Parkinson’s Disease
Post-Traumatic Stress Disorder (PTSD)
Sickle Cell Anemia
Seizures
Severe, persistent muscle spasms
Terminal illness
Tourette’s Syndrome

Montana

In 2016, voters in Montana approved a new medical marijuana program, and as of January 1st, 2022, adult-use cannabis is now legal to purchase in licensed dispensaries.

Qualifying health conditions for Montana’s medical marijuana program include:

A CNS disorder that results in muscle spasms or painful/chronic spasticity
Cachexia or Wasting Syndrome
Cancer
Chronic Inflammatory Demyelinating Polyneuropathy
Crohn’s Disease
Epilepsy or an Intractable Seizure Disorder
Glaucoma
HIV/AIDS
Hospice Care
Multiple Sclerosis
Post-Traumatic Stress Disorder (PTSD)
Severe nausea or pain

Nevada

Nevada has allowed patients to grow medical cannabis since 2000 and legalized the sale of medical cannabis in 2015. The Silver State legalized adult-use cannabis in July of 2017 and is a popular cannabis destination for people traveling into Las Vegas and Reno.

Qualifying health conditions for Nevada’s medical marijuana program include:

Anxiety
Anorexia Nervosa
Autism Spectrum Disorder
Autoimmune Disease
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Dependance upon or Addiction to Opioids
Epilepsy
Glaucoma
HIV/AIDS
Multiple Sclerosis
Muscle Spasms
Nausea
Neuropathy
Post-Traumatic Stress Disorder (PTSD)
Seizures

New Hampshire

New Hampshire signed their medical marijuana program into law in 2013, and decriminalized small amounts of cannabis in 2017.

Qualifying health conditions for New Hampshire’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Alzheimer’s disease
Cachexia or Wasting Syndrome
Cancer
Chemotherapy-induced anorexia
Chronic Pain (that has not responded to previously prescribed medication)
Chronic pancreatitis
Crohn’s disease
Ehlers-Danlos syndrome
Elevated intraocular pressure
Epilepsy
Glaucoma
Hepatitis C
HIV/AIDS
Lupus
Moderate to severe vomiting
Multiple Sclerosis
Muscular Dystrophy
Nausea
Parkinson’s disease
Persistent muscle spasms
Post-Traumatic Stress Disorder (PTSD)
Seizures
Spinal cord injury or disease
Terminal Illness
Traumatic brain injury
Ulcerative Colitis

New Jersey

Medicinal cannabis has been legal in New Jersey since 2010, and The Garden State officially legalized adult-use cannabis in February 2021, where the market is set to launch in 2022.

Qualifying health conditions for New Jersey’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Anxiety
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Crohn’s disease
Dysmenorrhea
Epilepsy
Glaucoma
HIV/AIDS
Inflammatory bowel disease (IBD)
Intractable skeletal, muscular spasticity
Migraines
Multiple Sclerosis
Muscular Dystrophy
Nausea
Opioid use disorder
Post-Traumatic Stress Disorder (PTSD)
Seizures
Tourette’s Syndrome
Any terminal illness if a doctor has determined the patient will die within a year.

New Mexico

New Mexico has allowed patients with one of the following conditions to use medicinal cannabis and to grow as many as four mature weed plants at a time since 2007. As of June 29th, 2021, Mexico legalized adult-use cannabis.

Qualifying health conditions for New Mexico’s medical marijuana program include:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s disease)
Anorexia
Autism Spectrum Disorder
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Crohn’s disease
Damage to the Nervous Tissue of the Spinal Cord
Epilepsy
Friedreich’s Ataxia
Glaucoma
Hepatitis C
HIV/AIDS
Hospice patients
Huntington’s disease
Inclusion Body Myositis
Inflammatory Autoimmune-mediated Arthritis
Intractable nausea/vomiting
Lewy Body Disease
Multiple sclerosis
Obstructive Sleep Apnea
Opioid Use Disorder
Painful Peripheral Neuropathy
Parkinson’s disease
Post-traumatic Stress Disorder (PTSD)
Seizures
Spasmodic Torticollis (Cervical Dystonia)
Spinal Muscular Atrophy
Ulcerative Colitis

New York

As of January 24th, 2022, New York dropped qualifying conditions for the medical marijuana program and now allows physicians and other medical practitioners to prescribe medical cannabis for any condition if they believe that cannabis is an appropriate treatment.

New York has also permanently waived the $50 patient application fee, expanded the type of practitioners that can prescribe cannabis, allowed the sale of flower, and several other modifications. This is in tandem with NY passing a bill in September 2021 that fully legalized adult-use cannabis, which is slated to be the next billion-dollar market for the state, the east coast, and the country. Regulations are currently being drafted with the first legal sales soon to follow sometime during late 2022.

North Carolina

North Carolina legalized the use of CBD oil in 2015. It does not appear that you need any health conditions or physicians’ recommendation to purchase CBD. There are currently talks about a proposed Medical Marijuana program that could potentially be further discussed and voted on sometime later in 2022. It is said it might be one of the tightest bills in the country with limited qualifications but we will see as the talks develop.

North Dakota

North Dakota legalized medical marijuana during the 2016 elections.

Qualifying health conditions for North Dakota’s medical marijuana program include:

Agitation from Alzheimer’s disease or related dementia
Amyotrophic lateral sclerosis (ALS/ Lou Gehrig’s Disease)
Anorexia Nervosa
Anxiety Disorder
Autism Spectrum Disorder
Brain Injury
Bulimia Nervosa
Cachexia or Wasting syndrome
Cancer
Chronic or debilitating disease
Crohn’s disease
Ehlers-Danlos Syndrome
Endometriosis
Epilepsy
Fibromyalgia
Glaucoma
Hepatitis C
HIV/AIDS
Interstitial Cystitis
Intractable nausea
Neuropathy
Migraine
Multiple sclerosis
Post-traumatic stress disorder (PTSD)
Rheumatoid Arthritis
Seizures
Severe and persistent muscle spasms
Severe debilitating pain
Spinal stenosis
Tourette’s Syndrome

Ohio

Ohio decriminalized cannabis in 1975 and signed a medical marijuana bill in 2016. Dispensaries were officially permitted to open in late 2018.

Qualifying health conditions for Ohio’s medical marijuana program include:

Alzheimer’s disease
Amyotrophic lateral sclerosis (ALS/ Lou Gehrig’s disease)
Cachexia or Wasting Syndrome
Cancer
Chronic traumatic encephalopathy
Crohn’s disease
Epilepsy
Fibromyalgia
Glaucoma
Hepatitis C
HIV/AIDS
Huntington’s Disease
Inflammatory bowel disease
Multiple Sclerosis
Pain that is either of the following nature: (i) Chronic and severe; or (ii) Intractable
Parkinson’s disease
Post-traumatic stress disorder (PTSD)
Seizures
Sickle cell anemia
Spasticity
Spinal cord disease or injury
Terminal Illness
Tourette’s syndrome
Traumatic brain injury
Ulcerative colitis

Oklahoma

Oklahoma’s medical marijuana program took effect in 2018 and does not have a defined list of qualifying conditions, as you only need the recommendation of a licensed physician. Below is a list of common conditions that allow patients to purchase medical marijuana.

Qualifying health conditions for Oklahoma’s medical marijuana program include:

Anxiety Disorders
Body Aches
Cachexia or Wasting Syndrome
Cancer
Depression
Epilepsy
Glaucoma
HIV/AIDS
Inflammation
Loss of appetite
Migraines
Muscle pain
Nausea
Neuropathic pain disorders
Seizures

Oregon

Oregon is a hotbed for cannabis. The state legalized medical cannabis through voting in 1998 and adult-use cannabis in 2014.

Qualifying health conditions for Oregon’s medical marijuana program include:

Alzheimer’s disease
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Glaucoma
HIV or AIDS
Nausea
Persistent muscle spasms
Post-traumatic Stress Disorder (PTSD)
Seizures
Other conditions are subject to approval.

Pennsylvania

Pennsylvania legalized medical cannabis in the spring of 2016. The Pennsylvania Medical Marijuana Program officially launched in 2018. Patients can click the link to register for a medical marijuana card.

Qualifying health conditions for Pennsylvania’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Anxiety Disorders
Autism
Cancer
Crohn’s disease
Damage to the nervous tissue of the Central Nervous System (brain-spinal cord)
Dyskinetic and spastic movement disorders
Epilepsy
Glaucoma
HIV/AIDS
Huntington’s disease
Inflammatory bowel disease (IBD)
Intractable seizures
Intractable spasticity
Multiple Sclerosis
Neurodegenerative Diseases
Neuropathies
Opioid use disorder
Parkinson’s disease
Post-Traumatic Stress Disorder (PTSD)
Severe chronic or intractable pain
Sickle Cell Anemia
Terminal illness
Tourette’s Syndrome

Rhode Island

Rhode Island’s medical cannabis laws went into effect in 2006, and The Ocean State decriminalized cannabis in 2013.

Qualifying health conditions for Rhode Island’s medical marijuana program include:

Alzheimer’s Disease
Cachexia or Wasting Syndrome
Cancer
Chronic pain
Crohn’s disease
Epilepsy
Glaucoma
Hepatitis C
HIV/AIDS
Multiple Sclerosis
Nausea
Persistent muscle spasms
Post-traumatic stress disorder
Seizures
Other conditions are subject to approval.

South Carolina

On February 10th, 2022, South Carolina’s Senate approved a Medical Marijuana Legalization Bill (S. 150). The proposed legislation is now headed to the House of Representatives for consideration.

Though not legalized just yet, qualifying health conditions for South Carolina’s medical marijuana program include:

A condition causing a person to be homebound that includes severe or persistent nausea
A chronic medical condition causing severe and persistent muscle spasms
Autism
Cachexia or Wasting Syndrome
Cancer
Crohn’s Disease
Chronic medical condition for which an opioid is or could be prescribed based on standards of care
Multiple Sclerosis
Neurological disease or disorder (including epilepsy)
Post-Traumatic Stress Disorder
Sickle Cell Anemia
Terminal Illness
Ulcerative Colitis

South Dakota

South Dakota legalized medicinal cannabis in 2020, and its program became operational on July 1st, 2021. The adult-use market could soon follow as a bill proposed to legalize cannabis has passed the senate and is being sent to the floor, along with a separate measure that passed the week prior to set up a tax scheme for the adult-use market if legalization is enacted.

Qualifying health conditions for South Dakota’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Crohn’s Disease
Epilepsy
Glaucoma
HIV/AIDS
Multiple Sclerosis
Nausea or severe vomiting
Post-Traumatic Stress Disorder (PTSD)
Seizures

Tennessee

In Tennessee, the medical cannabis bill only allows for the use of CBD oil.

Qualifying health conditions for Texas’s medical CBD program include:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Cancer and related conditions
Crohn’s Disease
Epilepsy
HIV/AIDS
Inflammatory Bowel Disease (IBD)
Multiple Sclerosis
Parkinson’s Disease
Seizures
Sickle Cell Disease
Ulcerative Colitis

Texas

Texas has taken a long time to develop a medical marijuana program. In September 2017, the state finally issued medical marijuana licenses and expanded its relatively limited program in 2019 and 2021.

Qualifying health conditions for Texas’s medical marijuana program include:

Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
An incurable neurodegenerative disease
Autism
Epilepsy
Multiple Sclerosis
Post-Traumatic Stress Disorder
Seizures
Spasticity
Terminal Cancer

Utah

Utah passed the Utah Medical Cannabis Act and launched its program in December 2018.

Qualifying health conditions for Utah’s medical marijuana program include:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Autism
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Crohn’s Disease
Epilepsy
HIV/AIDS
Hospice Patient
Multiple Sclerosis
Nausea
Persistent and debilitating muscle spasms
Post-Traumatic Stress Disorder (PTSD)
Rare condition or disease that affects less than 200,000 individuals in the U.S., as defined in federal law, and that is not adequately managed despite treatment attempts using conventional medications (other than opioids or opiates) or physical interventions
Seizures
Terminal Illness
Ulcerative Colitis

Vermont

Vermont legalized medical cannabis in 2004 and adult-use cannabis in 2018.

Qualifying health conditions for Vermont’s medical marijuana program include:

Cachexia or wasting syndrome
Cancer
Crohn’s disease
Epilepsy
Glaucoma
HIV/AIDS
Multiple Sclerosis
Parkinson’s disease
Post-Traumatic Stress Disorder (PTSD)
Seizures
Severe or chronic pain
Severe nausea

Virginia

In 2017, Virginia legalized the use of some types of cannabis oil for patients with epilepsy. It was in April 2021 that they legalized both medicinal and adult-use cannabis and as of July 1st, 2021, Patients with any recommendation of a licensed Virginia Physician or nurse practitioner can participate in the Medical Marijuana Program. The first legal sales for the adult-use market are slated to be sometime in 2024.

Qualifying health conditions for Virginia’s medical marijuana program include, but are not limited to:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS/ Lou Gehrig’s Disease)
Anxiety
Autism
Cachexia or Wasting Syndrome
Cancer
Chronic Pain
Crohn’s Disease
Epilepsy
Fibromyalgia
Hepatitis C
Huntington’s Disease
Inflammatory Bowel Disease (IBD)
Multiple Sclerosis (MS)
Parkinson’s Disease
Post-Traumatic Stress Disease (PTSD)
Seizures
Sickle Cell Anemia
Tourette’s Syndrome

Washington

Washington legalized medical cannabis through the ballot in 1998 and adult-use cannabis in 2012.

Qualifying health conditions for Washington’s medical marijuana program include:

Anorexia Nervosa
Appetite Loss
Cachexia or Wasting Syndrome
Cancer
Chronic renal failure requiring hemodialysis
Crohn’s disease
Epilepsy
Glaucoma
Hepatitis C
HIV/AIDS
Intractable pain
Multiple Sclerosis
Nausea
Persistent muscle spasms and/or spasticity
Post-Traumatic Stress Disorder (PTSD)
Seizures
Traumatic brain injury
Any terminal or debilitating condition.

West Virginia

West Virginia legalized medical marijuana in 2017 when they signed bill SB 386 into law.

Qualifying health conditions for West Virginia’s medical marijuana program include:

Amyotrophic lateral sclerosis (ALS/ Lou Gehrig’s Disease)
Cancer
Crohn’s disease
Epilepsy
HIV/AIDS
Huntington’s disease
Intractable seizures
Intractable Spasticity
Multiple sclerosis
Neuropathy
Parkinson’s disease
Post-Traumatic Stress Disorder (PTSD)
Severe chronic or intractable pain
Spinal cord damage
Sickle cell anemia
Terminal illness

Wisconsin

Wisconsin signed a CBD-only medical cannabis program into law in 2014.

Qualifying health conditions for Wisconsin’s medical CBD program include:

Any medical condition for which a patient receives the proper doctor recommendations.

Wyoming

Wyoming signed a CBD-only medical cannabis law in 2015.

Qualifying health conditions for Wyoming’s medical CBD program include:

Intractable epilepsy

Washington, D.C.

Washington, D.C., has relatively liberal cannabis laws. The District passed medical cannabis legislation in 2010 and adult-use cannabis in 2014. Patients could receive MMJ for “any condition for which treatment with medical marijuana would be beneficial, as determined by the patient’s physician.” For examples of qualifying conditions, please refer to any of the lists above.

Final Hit: Qualifying Health Conditions For Medical Marijuana

As this list makes clear, medical marijuana can take a variety of shapes. Currently, one in five Americans can access some form of legal cannabis. But laws between states vary dramatically.

Source: Medical Marijuana Blog

View Original Post

Qualifying Conditions for Medical Marijuana